Dale Schaar, MD, PhD
Schaar, Dale
Medical Oncologist
Rutgers Cancer Institute of New Jersey
Online Profile:
patient
ASTEX PHARMACEUTICALS PRESENTS OVERALL SURVIVAL DATA FROM ASCERTAIN PHASE 3 STUDY OF ORAL HYPOMETHYLATING AGENT INQOVI® (DECITABINE AND CEDAZURIDINE) IN MDS AND CMML AT INTERNATIONAL CONGRESS ON MYELODYSPLASTIC SYNDROMES
Study achieved median overall survival of 31.7 months
Updated efficacy data demonstrated an overall response rate of 62%, with 22% of patients achieving a complete response
INQOVI is the only oral hypomethylating agent with equivalent exposure to its intravenous (IV) form
AML Management: Feel Better With Food and Physical Activity
Eric Yang, MD
Yang, Eric
Associate Clinical Professor of Medicine
Ronald Reagan University of California, Los Angeles Medical Center
Dr. Eric Yang is currently an Associate Clinical Professor of Medicine at the Ronald Reagan University of California, Los Angeles Medical Center. He obtained his undergraduate and medical degrees at the University of Illinois at Chicago College of Medicine, and completed his internal medicine residency and cardiology fellowship at Harbor-UCLA Medical Center, where he served as chief fellow.
Online Profile:
Anthony Hunter, MD
Hunter, Anthony
Assistant Professor in the Department of Hematology and Medical Oncology
Winship Cancer Institute of Emory University
Anthony M. Hunter, MD, is an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A hematologist, Dr.
"I Chose Life" - Debra Reflects on Three Years of Challenges with Aplastic Anemia
Person's Name:
Debra O'Neal
“Your blood counts are nearly nonexistent,” the doctor said.
Before this moment, Debra considered herself to be generally healthy, just tiring easily. She assumed the cause was the big project at work on top of a host of family and volunteer activities, or perhaps issues with her blood pressure. It was autumn of 2017.
Bone Marrow Disease(s):
Content source:
Eunice Wang, MD
Wang, Eunice
Chief of Leukemia Service
Roswell Park Comprehensive Cancer Center
Dr. Eunice Wang is the Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center. Dr. Wang joined the Roswell Park faculty in 2003 and was appointed to the Leukemia Service of the Department of Medicine. She earned her medical degree from the Keck School of Medicine, University of Southern California and completed residency training in Internal Medicine at Yale-New Haven Hospital, Yale University, New Haven, CT in 1999. From 1999 to 2003, she completed a clinical hematology-oncology and research fellowship at Memorial Sloan Kettering Cancer Center in New York, NY.
Online Profile:
Swapna Thota, MD
Thota, Swapna
Assistant Professor of Medicine
University of Tennessee
As a physician caring for patients with acute leukemias and related disorders, I have a sustained focus on translational research in hematologic malignancies. Genomic sequencing technology revolutionized our understanding of cancer biology. My research focuses on exploring the dynamic changes of tumor immune microenvironment with clonal evolution of myeloid malignancies. Targeting inflammaging of
Online Profile:
This is Your Brain on (Chemo) Drugs - Summer 2021 Conference
Dr. Elizabeth Bowhay-Carnes
Bowhay-Carnes, Elizabeth
Hematologist/Oncologist
UT Health - San Antonio
Dr. Elizabeth Bowhay-Carnes is a Texas native and passionate about serving the people of her home community. She earned her bachelors of science degree in biochemistry from the University of Texas at Austin, followed by work with the MD Anderson Cancer Center Umbilical Cord Blood Bank in Houston. She received her medical doctorate from UT Health San Antonio and completed her residency in internal medicine and fellowship in hematology and medical oncology at the UT Health Science Center.
Online Profile: